Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …

To the Editor: Cancer and cardiovascular disease constitute the two major causes of death
worldwide. Whereas the incidence of cancer increases among adults up to 74 years of age …

Modern cancer therapy employs a combination of chemotherapy, antibody-based therapy,
radiotherapy, and surgery to prolong life and provide cure. However, many of the …

Monoclonal antibodies are currently used in the treatment of neoplastic, hematological, or
inflammatory diseases, a practice that is occasionally associated with a variety of systemic …

The field of cardio-oncology was born from the necessity for recognition and management of
cardiovascular diseases among patients with cancer. This need for this specialty continues …

This accomplishment, however, has been achieved at the expense of significant short-term
and long-term toxicities, including cardiovascular (CV) complications. Chemotherapy and …

Cardiology and oncology are two fields dedicated to the study of various types of
oncological and cardiac diseases, but when they collide, a new specialty is born, ie, cardio …

Cardiovascular side effects of cancer treatments are common and might affect the survival in
cancer patients. Recognition and management of these side effects require understanding …

Over the last decade, the advent of molecular targeted therapy radically changed the
treatment of several forms of cancer. However, these innovative anticancer drugs, namely …

Despite current advancements in chemotherapy, immunotherapy and targeted treatments,
the potential for major adverse cardiovascular events, regardless of previous cardiac history …